HilleVax, Inc.
HLVXDelisted Sep 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001888012
HilleVax, Inc. was delisted on Sep 17, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 74 institutions reported holding it in 13F filings for Q2 2025, worth $82.5M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in HilleVax, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 57
- +57 vs. Q1 2022
- Shares held
- 23.2M
- +23.2M vs. Q1 2022
- Total value
- $253.7M
- +$253.7M vs. Q1 2022
- New holders
- 57
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HLVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 74 | $82.5M |
| Q1 2025 | 81 | $61.1M |
| Q4 2024 | 76 | $88.7M |
| Q3 2024 | 79 | $73.5M |
| Q2 2024 | 94 | $657.8M |
| Q1 2024 | 81 | $730.0M |
| Q4 2023 | 69 | $678.3M |
| Q3 2023 | 68 | $459.3M |
| Q2 2023 | 54 | $436.6M |
| Q1 2023 | 61 | $436.2M |
| Q4 2022 | 55 | $440.2M |
| Q3 2022 | 51 | $399.9M |
| Q2 2022 | 57 | $253.7M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding HilleVax, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 15 | $0 | 0.00% | +15 | New |
| Credit Suisse AG | 10 | $0 | 0.00% | +10 | New |
| Royal Bank of Canada | 73 | $1.00K | 0.00% | +73 | New |
| Wells Fargo & Company | 195 | $2.00K | 0.00% | +195 | New |
| UBS Group AG | 571 | $6.00K | 0.00% | +571 | New |
| Barclays PLC | 650 | $7.00K | 0.00% | +650 | New |
| Citigroup Inc | 795 | $9.00K | 0.00% | +795 | New |
| Cubist Systematic Strategies, LLC | 800 | $9.00K | 0.00% | +800 | New |
| Ameritas Investment Partners, Inc. | 972 | $10.0K | 0.00% | +972 | New |
| Amalgamated Bank | 1,722 | $19.0K | 0.00% | +1,722 | New |
| Tower Research Capital LLC (TRC) | 2,372 | $26.0K | 0.00% | +2,372 | New |
| STRS Ohio | 3,000 | $32.0K | 0.00% | +3,000 | New |
| Bank of America Corp | 3,915 | $43.0K | 0.00% | +3,915 | New |
| California State Teachers Retirement System | 5,542 | $61.0K | 0.00% | +5,542 | New |
| American International Group, Inc. | 6,066 | $66.0K | 0.00% | +6,066 | New |
| Deutsche Bank AG | 6,127 | $67.0K | 0.00% | +6,127 | New |
| JPMorgan Chase & Co | 6,929 | $76.0K | 0.00% | +6,929 | New |
| Point72 Hong Kong Ltd | 6,950 | $76.0K | 0.00% | +6,950 | New |
| ETF Managers Group, LLC | 9,539 | $97.0K | 0.00% | +9,539 | New |
| New York State Common Retirement Fund | 9,300 | $102.0K | 0.00% | +9,300 | New |
| Boothbay Fund Management, LLC | 10,449 | $114.0K | 0.00% | +10,449 | New |
| Sandia Investment Management LP | 12,500 | $137.0K | 0.02% | +12,500 | New |
| Point72 Asset Management, L.P. | 15,000 | $164.0K | 0.00% | +15,000 | New |
| Caas Capital Management LP | 15,000 | $164.0K | 0.02% | +15,000 | New |
| Millennium Management LLC | 16,949 | $185.0K | 0.00% | +16,949 | New |
| Rhumbline Advisers | 17,098 | $187.0K | 0.00% | +17,098 | New |
| Nuveen Asset Management, LLC | 18,369 | $201.0K | 0.00% | +18,369 | New |
| Squarepoint Ops LLC | 18,368 | $201.0K | 0.00% | +18,368 | New |
| TD Asset Management Inc | 18,528 | $203.0K | 0.00% | +18,528 | New |
| Alps Advisors Inc | 19,825 | $217.0K | 0.00% | +19,825 | New |
| Susquehanna International Group, LLP | 22,890 | $250.0K | 0.00% | +22,890 | New |
| Blackstone Group Inc. | 25,000 | $273.0K | 0.00% | +25,000 | New |
| Bank of New York Mellon Corp | 31,544 | $344.0K | 0.00% | +31,544 | New |
| Seven Grand Managers, LLC | 34,386 | $376.0K | 0.85% | +34,386 | New |
| Alyeska Investment Group, L.P. | 42,312 | $462.0K | 0.01% | +42,312 | New |
| Ghisallo Capital Management LLC | 60,000 | $656.0K | 0.08% | +60,000 | New |
| Charles Schwab Investment Management Inc | 90,665 | $991.0K | 0.00% | +90,665 | New |
| UBS Oconnor LLC | 90,943 | $994.0K | 0.01% | +90,943 | New |
| Morgan Stanley | 104,102 | $1.14M | 0.00% | +104,102 | New |
| Northern Trust Corp | 104,745 | $1.15M | 0.00% | +104,745 | New |
| Fred Alger Management, LLC | 107,710 | $1.18M | 0.01% | +107,710 | New |
| Two Sigma Investments, LP | 130,000 | $1.42M | 0.00% | +130,000 | New |
| State Street Corp | 164,172 | $1.79M | 0.00% | +164,172 | New |
| Geode Capital Management, LLC | 219,507 | $2.40M | 0.00% | +219,507 | New |
| BVF Inc | 382,513 | $4.18M | 0.20% | +382,513 | New |
| Qiming U.S. Ventures Management, LLC | 558,923 | $6.11M | 8.48% | +558,923 | New |
| Vanguard Group Inc | 610,807 | $6.68M | 0.00% | +610,807 | New |
| Franklin Resources Inc | 672,512 | $7.35M | 0.00% | +672,512 | New |
| StepStone Group LP | 676,567 | $7.39M | 0.79% | +676,567 | New |
| BlackRock Inc. | 737,182 | $8.06M | 0.00% | +737,182 | New |
| Samsara BioCapital, LLC | 762,577 | $8.34M | 2.23% | +762,577 | New |
| Perceptive Advisors LLC | 764,907 | $8.36M | 0.26% | +764,907 | New |
| Price T Rowe Associates Inc | 1,101,237 | $12.0M | 0.00% | +1,101,237 | New |
| Ra Capital Management, L.P. | 1,760,019 | $19.2M | 0.51% | +1,760,019 | New |
| Abingworth LLP | 1,838,486 | $19.9M | 6.38% | +1,838,486 | New |
| Deerfield Management Company, L.P. (Series C) | 2,617,948 | $28.6M | 0.60% | +2,617,948 | New |
| Frazier Life Sciences Management, L.P. | 9,285,682 | $101.5M | 9.58% | +9,285,682 | New |